Related Experiment Video
Updated: Mar 9, 2026

06:20
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.8K
Opportunities for research in molecular radiotherapy
Glenn D Flux1, Joe O'Sullivan2, Mark N Gaze3
11 Joint Department of Physics, Royal Marsden NHS Hospital and Institute of Cancer Research, Sutton, UK.
The British Journal of Radiology
|January 6, 2017
Summary
Molecular radiotherapy, a cancer treatment, is gaining importance with new drugs. Increased research and investment are crucial for its potential in personalized medicine and theranostics.
Area of Science:
- Oncology
- Nuclear Medicine
Background:
- Radiopharmaceuticals have been used for cancer treatment for 80 years.
- Molecular radiotherapy is increasingly important in personalized medicine and theranostics.
- New commercial radiotherapeutics are being introduced at costs comparable to conventional chemotherapy.
Purpose of the Study:
- To review the current status of molecular radiotherapy.
- To identify barriers and opportunities for research in this field.
- To recommend actions to promote the advancement of molecular radiotherapy.
Main Methods:
- Review of a National Cancer Research Institute report.
- Analysis of the current landscape of molecular radiotherapy.
- Identification of key areas for future investigation.
Main Results:
- The report highlights barriers and opportunities for research in molecular radiotherapy.
- Recommendations include a multidisciplinary approach, investment in radiopharmacies and personalized dosimetry.
- Areas for investigation include adaptive treatment planning, radiosensitizers, and translational radiation biology.
Conclusions:
- Molecular radiotherapy holds significant potential for patient benefit and cost-effective cancer treatment.
- A concerted community effort, including funding and health service providers, is needed to overcome scientific and logistical challenges.
- Addressing these challenges will help realize the full potential of this underused treatment modality.
Related Concept Videos
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Biological Effects of Radiation
18.6K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
18.6K
Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K

